| Identification | Back Directory | [Name]
BMS 564929 | [CAS]
627530-84-1 | [Synonyms]
929
BMS-564
BMS 564929
BMS 564929;BMS564929
BMS-564929;BMS-564;929; BMS 564929
2-chloro-4-((7R,7aS)-7-hydroxy-1,3-dioxotetrahydro-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl)-3-methylbenzonitrile
2-Chloro-3-methyl-4-[(7R,7aS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl]benzonitrile
Benzonitrile, 2-chloro-3-methyl-4-[(7R,7aS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl]- | [Molecular Formula]
C14H12ClN3O3 | [MDL Number]
MFCD15146692 | [MOL File]
627530-84-1.mol | [Molecular Weight]
305.72 |
| Chemical Properties | Back Directory | [Boiling point ]
523.3±60.0 °C(Predicted) | [density ]
1.58±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 50 mg/mL (163.55 mM); Water: < 0.1 mg/mL (insoluble) | [form ]
neat | [pka]
13.38±0.20(Predicted) | [color ]
White to off-white | [BRN ]
11053870 |
| Hazard Information | Back Directory | [Uses]
BMS-564929 is a selective androgen receptor modulator that induces anabolic effects. Potential use in osteoporosis treatments; SARMs | [storage]
Store at -20°C |
|
|